Now that you know a little more about creative problem solving and the importance of health literacy, you will take the next step to approaching a problem by completing the initial phase of Creative Problem Solving

Now that you know a little more about creative problem solving and the importance of health literacy, you will take the next step to approaching a problem by completing the initial phase of Creative Problem Solving: Problem Scoping. This process establishes clear requirements for creating a viable final solution. It often is initiated by the identification of a need or issue. This part of the problem-solving process focuses on the issue/need by gathering and analyzing information. In other words, you will clearly define what needs to be done prior to creating an effective solution. This SLP will help you practice your problem-scoping skills by completing a clear, focused Problem Scoping Document. This will provide a clear problem definition and target for solution development.Problem Scoping Assignment Instructions:As you complete the problem-scoping phase, your proposed document will include the following information:

  • Develop a problem statement.
  • Determine any potential constraints.
  • Determine the criteria.
  • Identify the stakeholders.
  • Develop a procedure for gathering data prior to decision making.

Be sure to thoroughly complete and submit the Problem Scoping Document Template.Select a public health issue from the CDC website that you reviewed for Module 3 at http://www.cdc.gov/features/datastatistics.html and incorporate the information found there into a Problem Scoping document by following these steps:

  1. Determine what questions you would ask yourself:
    1. Scope of the problem—Part of the Problem Statement.
    2. When and where the problem occurs—Part of the Problem Statement.
    3. Impact—Part of the Problem Statement.
    4. Identify two criteria related to the problem statement that you created.
    5. Who is directly involved with the problem? Stakeholders?
  2. Determine how you would gather data important to educating the public on this issue.

THE CASE STUDY APPROACH AND PROBLEM SCOPING

THE CASE STUDY APPROACH AND PROBLEM SCOPING

Assignment Overview

In this Module 4 Case Assignment you will build upon the Problem Scoping analysis you prepared in your Module 3 SLP assignment by:

  1. Developing three alternative solutions that address the problem definition and criteria that you identified.
  2. Comparing the pros and cons of those three alternatives.
  3. Selecting the best alternative.
  4. Developing a logical argument to support your choice.

You will apply these same analytic skills throughout your health sciences program, and they will serve you very well in your professional life.

Case Assignment

Use the Evaluate Alternative Solutions Template to complete your Case Assignment.
Note: Developing alternative solutions is essentially a brainstorming process. What can you do to solve the problem? That is an alternative. Proposed alternatives should be consistent with the problem(s) that you identified in your Module 3 SLP assignment.
Developing a list of good alternatives involves creativity and avoiding preconceived attitudes (knee-jerk solutions) and assumptions. Guidelines for alternative development include:

  1. DON’T SETTLE FOR YOUR FIRST IDEA!
  2. Good designers try to generate as many possible solutions as they can before choosing one that they feel is the best. This creative process of developing ideas is called ideation.
  3. Methods of ideation include:
    1. Examine existing solutions
    2. Conduct brainstorming sessions. Remember the first rule of brainstorming – every idea is a viable one.
    3. Develop as many alternatives as possible. When you are done, try to categorize your alternatives. Then develop three alternatives.
    4. Sketching and doodling to create pictures of possible solutions.

Assignment Expectations

This assignment needs to be completed in paragraph format using full sentences. Insert the decision table you made into your Word document. Use this Insert Table file demonstrating techniques to Insert Tables into Word Documents.

Mental health processes and disorders originate from mechanisms within the brain. There has been the question within the psychiatric field as to whether plastic changes in the brain that can occur with the use of  pharmacological interventions for mental health disorders could also occur with the use of psychotherapy.

TO DO A REPLY COMMENT TO EACH POST. TWO REFERENCE PER COMMENT.
Post 1

Mental health processes and disorders originate from mechanisms within the brain. There has been the question within the psychiatric field as to whether plastic changes in the brain that can occur with the use of  pharmacological interventions for mental health disorders could also occur with the use of psychotherapy. Psychotherapy is extremely beneficial in treating several mental health issues (Laureate Education, 2016).There is compounding evidence that psychotherapy does have a biological basis and can have a positive impact in brain recovery from the stress response. According to Wheeler (2014), psychotherapy mediates the reintegration and connection of neural networks that have become maladaptively linked due to adverse life events facilitating healing of the brain. Psychotherapy has been found to be an effective treatment method for a variety of mental health disorders such as anxiety, major depression, and post-traumatic stress disorder. According to Fournier (2014), activity in regions associated with negative emotion, emotion regulation, fear, and reward are associated with respones to psychotherapy, and psychotherapy appears to alter the functioning of these regions.
While proven to be an effective treatment modality for mental health disorders, there are factors such as culture, religion, and socioeconomic background that can affect the client and their perspective on the use of psychotherapy. Psychotherapy within itself can bring conflicting emotions for the client and the clinician must be aware of how religion, culture, and socioeconomics can alter how the client perceives psychotherapy and its efficacy in their treatment. According to Wheeler (2014), the powerful influence of culture permeates all dimensions of out life in a way that is often unconscious. For example, if a client comes from a culture where emotions are not to be discusssed or if one discusses there past traumas or fears then the client could be resistant to the role of psychotherapy in their treatment plan. The clinician must be aware of the importance of culture in medical or psychological treatments. Religion also plays an instrumental role in how psychotherapy will be perceived by a client. Many clients may come from a religious background where one only speaks of negative emotions with someone from their clergy or a religious figure. According to Kim, Chen & Brachfeld (2018), religion and spirituality are important issues to consider and address in psychotherapy. Communication could become stagnant if the clinician is not aware of the role religion plays in the psychotherapy framework. Socioeconomic background can also be a variable in one‘s perspective of the value of psychotherapy. Certain traumatic events that a person can suffer throughout their lifetime can be directly correlated to socioeconomic standing. For example, poverty can be associated with depression, anxiety, substance abuse, and mood disorders. Patients from this type of background can experience barriers in both seeking and receiving mental health services. According to Bernal et al. (2017), vulnerable populations such as those low in social status face additional barriers to mental health treatment and experience unique barriers to receiving optimal care.

References

Bernal, D.R., Herbst, R.B., Lewis, B.L., & Feibelman, J. (2017). Ethical care for vulnerable populations receiving psychotropic treatment. Ethics & Behavior, 27(7), 582-598. doi:10.1080/10508422.2016.1224187
Fournier, J.C., & Price, R.B. (2014). Psychotherapy and neuroimaging. Psychotherapy: New Evidence and New Approaches, 12(3), 290-298. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207360
Kim, E.E., Chen, E.C., & Brachfeld, C. (2018). Patients’ experience of spirituality and change in individual psychotherapy at a Christian counseling clinic: A grounded theory analysis. Spirituality in Clinical Practice, doi:10.1037/scp0000176
Laureate Education (Producer). (2016). Introduction to psychotherapy with individuals [Video file]. Baltimore, MD: Author.
Wheeler, K. (Eds.). (2014). Psychotherapy for the advanced practice psychiatric nurse: A how-to guide for evidence-based practice (2nd ed.). New York, NY: Springer Publishing Company.
POST 2
Psychotherapy is just as controversial as mental health as a whole is. Some believe it is helpful, others believe it is a waste of time. One question still remains unanswered for many, can talking about feelings help change behavior and therefore sure whatever condition a person is suffering from? I believe psychotherapy has a biological basis. Lyrakos, Spinaris, and Spyropoulos (2017) clearly stated as results of a research that “the use of psychotherapy plays a significant role in achieving optimal health outcomes of psychiatric patients” (p. s753). Pairing psychopharmacology with psychotherapy can make a positive impact towards recovery compared to treatment with just psychopharmacology.
Many different reasons can influence the belief that psychotherapy might or might not work. For example, Adams et al. (2017) concluded in an article that “findings suggest that patients’ attachment characteristics play a role in their views and choices regarding treatments” (p. 194). Other factors that can impact the belief that therapy is a waste of time are culture, religion, and socioeconomic status. A person’s upbringing can be one to avoid talking about feelings with a stranger, or even with a loved one. Religion can also play a role in not receiving this type of treatment as faith in a spiritual belief might be the perceived as the cure to an ailment. Economical status and education level can also negatively impact the decision to avoid this type of treatment as the importance of it might not be completely comprehended or there are no means to afford the treatment. In another study that correlates the importance of psychotherapy, data showed “that children/adolescents with not only behavioral and emotional disorders, but also affective (mood) disorders had a higher chance for nondrug psychiatric/psychotherapeutic treatment compared to children with other psychiatric disorders” (Abbas et al., 2017, p. 442).
References
Lyrakos, G., Spinaris, V., & Spyropoulos, I. (2017). The introduction of psychotherapy in
psychiatric outpatients as part of the treatment in the last four years in a Greek
hospital. European Neuropsychopharmacology, 27(4).
Adams, G. C., McWilliams, L. A., Wrath, A. J., Adams, S., & Souza, D. D. (2017).
Relationships between patients’ attachment characteristics and views and use of
psychiatric treatment. Psychiatry Research, 256:194-201.
Abbas, S., Ihle, P., Adler, J., Engel, S., Günster, C., Holtmann, M., & …Schubert, I. (2017).
Predictors of non-drug psychiatric/psychotherapeutic treatment in children and
adolescents with mental or behavioral disorders. European Child & Adolescent
            Psychiatry, 26(4).

An agonist to antagonist to inverse agonist spectrum

TO DO A REPLY COMMENT TO POST 1 and 2 WITH TWO APA REFERENCES EACH ABOVE 2013.
POST 1
An agonist to antagonist to inverse agonist spectrum
Psychoactive medications vary in how they affect activity at the synapse.  Agonists increase the neurotransmitter effect while antagonists block the neurotransmitter effect (Barron, 2018). There are gradients of how medications act creating a spectrum of influence on receptors.  Agonists can occur naturally as neurotransmitters that stimulate receptors.  Some medications also act as agonists to stimulate receptors, but medications can stimulate receptors to varying degrees (Stahl, 2013).  This creates the spectrum of how medications variably affect neurotransmitters.  The medications that stimulate receptors but do so less than full agonists are partial agonists or stabilizers.  Antagonists have no activity of their own except to block the activity of the agonists, sometimes antagonists are called silent (Stahl, 2013).  At the opposite end of the spectrum from agonists are inverse agonists. These medications block agonists and decrease activity to below the normal baseline level when there is no agonist present (Stahl, 2013).
G Couple proteins and Ion gated channels
Ion gated channels are proteins that form pores in cell membranes (Inanobe & Kurachi, 2014).  These pores are the channels that allow movement across the cell membrane and are controlled by several mechanisms. The pore may open due to the voltage difference across the membrane (Ianonobe & Kurachi, 2014).  Ligand-gated channels have a domain extracellular that associates with small chemicals and regulatory proteins (Ianonobe & Kurachi, 2014).  A domain is a protein that has its own stable structure (Genscript, 2018). Ion channels gated by ligands can be opened or closed by a neurotransmitter that is specific to a ligand binding and causing a very short, brief open active state that occurs in milliseconds (Inanobe & Kurachi, 2014).  The ligand-gated channels can also be opened when metabotropic receptors that have G protein-coupled receptors are stimulated by G protein signaling (Inanobe & Kurachi, 2014).  The G protein-coupled ion gated open response is slower and is longer lived than the neurotransmitter ion channel opening (Ianonobe & Kurachi, 2014).  In summary, an ion gated channel is a throughway to the cell and this throughway is stimulated to be opened or closed by various mechanisms.  One of the ways the ion gated channel is stimulated to open is through G couple proteins.
Epigenetics in pharmacologic action
Genes are inherited from each parent.  But epigenetics looks at if the gene is developed into its specific RNA and protein or if the gene is silenced and ignored (Stahl, 2013).  Childhood stress has been found to deactivate the receptors for glucocorticoids (Rosenfield & Ziff, 2018).  Because the receptors are deactivated people grow up with disrupted feedback.  The glucocorticoids continue to be made by the body in greater amounts because they are not detected normally.  DNA methylation occurs and creates a barrier to normal genetic codes (Rosenfield & Ziff, 2018).  Long-term effects from childhood stressors are chronic inflammation, diabetes, heart disease, obesity, schizophrenia and major depressive disorder (Rosenfield & Ziff, 2018).  Cells including neurons respond to life stressors by reacting to genetics.  Genes may be silenced or activated but the expression of genetics can vary depending on stress (Stahl, 2013).
Possible Impact on Clients
Psychopharmacology is important because of the impact interactions can have on patients.  As future prescribers, it is important to be aware of patient differences and how illness affect patient’s ability to metabolize medications (Laureate Education, 2012).  It is also important to be aware of drug interactions with other medications, foods, and metabolism.  For example, Wellbutrin is primarily metabolized by CYP2B6.  So, Wellbutrin can react with other medications that are inhibitors or inducers of CYP2B6 (Drugs.com, 2018).  Plavix and Ticlid are CYP2B6 inhibitors and can increase bupropion levels (Drugs.com, 2018).  People also metabolize medications differently.  There are four classes of metabolizers from ultra-extensive metabolizers to poor metabolizers (Barron, 2018).  Knowing the type of metabolizer that the patient is can be helpful in tailoring their medication and dosage.  Epigenetics teaches us that people with trauma can have their gene expression altered by DNA methylation.  Trauma can lead to metabolic type diseases as well as depression and schizophrenia.  As a client example, a 17-year-old male was admitted for being increasingly physically and verbally abusive to his entire foster family.  The client had pushed down a foster brother and punched and kicked his foster mom and dad.  This client had been taken away from his biological mom around age 5 due to her drug use, neglect then jail.  He was then placed with his maternal grandmother who could not handle his behavior.  The client then was placed in numerous foster homes for brief periods of time.  He acted appropriately in the Psychiatric care center, so he could control his behavior when multiple security/ authority figures were present.  The client had been on Wellbutrin at home and when he had symptoms of insomnia and aggression his Wellbutrin was increased.  He was taken off Wellbutrin and started on another medication.  Some of the more common side effects of Wellbutrin are sleep disturbance (45%), agitation (32%), irritability, and anxiety (Drugs.com, 2018).  This patient’s history of trauma and aggression set him up for depression, anxiety and irritability then when he had increased symptoms with the medication it was increased to the maximum dose as an outpatient.  He became increasingly agitated and then violent which led to his admission to an inpatient psychiatric facility.
References
Barron, S. (2018). Psychopharmacology. Nobia textbook series:  Psychology. https://doi.org/nobaproject
Drugs.com. (2018). Wellbutrin. Retrieved from https://www.drugs.com/pro/wellbutrin.html
Genscript. (2018). Domain. Retrieved from https://www.genscript.com/molecular-biology-glossary/819/domain
Inanobe, A., & Kurachi, Y. (2014, February). Membrane channels as integrators of G-protein mediated signaling. Biochimica et Biophysica Acta (BBA) Biomembranes, 1838(2), 521-531. https://doi.org/10.1016/j.bbamem.2013.08.018
Laureate Education. (2012). Introduction to advanced pharmacology[Video file]. Retrieved from Walden University
Rosenfield, I., & Ziff, E. (2018). Epigenetics:  The evolution revolution. Retrieved from https://www.nybooks.com/articles/2018/06/07/epigenetics-the-evolution-revolution/
Stahl, S. M. (2013). Stahl’s essential psychopharmacology:  Neuroscientific basis and practical applications (4th ed.). Retrieved from https://stahlonline-cambridge-org.ezp.waldenulibrary.org
POST 2
Agonist to Antagonist Spectrum
Most drugs act as either agonists or antagonists at receptors in response to chemical messages in the brain.  An agonist, which can be described as partial or inverse, binds to the receptor to produce an effect.  Antagonists also bind to receptors but does not produce a response, rather blocks that receptor to a natural agonist (Pleuvry, 20004).  It is important to acknowledge that agonists and inverse agonists can be reversed by competitive antagonists.  In reference to atypical psychotropic drugs (APD), the blockade of serotonin receptors (5-HT2A) along with the weak antagonism of dopamine receptor (D2) is critical in potency and efficacy, as typical APD have tendency to antagonize D2 receptors more potently than 5-HT2A receptors (Kusumi, Boku, & Takahashi, 2014).
G-coupled Protein and Ion-gated Channels
G-protein linked receptors are important to clinicians with to target specific receptors with psychotropic drugs (Stahl, 2013).  Nonetheless, all agonists do not produce an active state of G-protein-coupled-receptors as in constitutive activity of receptors for benzodiazepines, serotonin, and other G-protein linked receptors.  Contrarily, ion channels function as a result of neurotransmitter ligands at receptors.  Numerous drugs act at ion-channel complexes altering flow of ions through the channels due to the transduction of the signal at receptors (Stahl, 2013).  As a result of the changes of flow of ions, drugs that act on ionotropic receptors tend to act immediately while G-protein linked receptors act at lower frequencies.
Epigenetics in Pharmacologic Action
The lack of response to standard therapies in certain individuals because of various molecular alterations can be due to genetic heterogenecity and epigenetic alterations (Rasool et al., 2015).  Epigenetic modifications can occur as a result of various chemical compounds in the biological system, changing gene expression.  Environmentally and biologically influenced alterations can lead to disorders, therefore clients with epigenetic alterations may require drugs used for personalized medicine based on their personal genomic profile.
Impact on How Medicine is Prescribed
Understanding the agonistic/antagonistic effects of medications along with the prescribing of medications specific to G-protein coupled receptors, and personalized medication profiles required by epigenetic alterations found in certain cases is important to PMHNP’s who may prescribe psychotropic medications to these clients.  Studies have found an existence of constitutive receptor activity in benzodiazepine receptors and G-protein coupled receptors and may be present in mutated strains exhibiting underactive behavior that can lead to inherited diseases such as congenital hypothyroidism and diabetes insipidus (Rasool et al., 2015).  For schizophrenic clients at greater risk for developing extrapyramidal symptoms (EPS), it is known that risperidone equally occupies D2 and 5-HT2A receptors increasing the frequency of EPS, while clozapine more potently occupies 5-HT2A receptors than D2 receptors, rarely producing EPS (Kusumi, Boku, & Takahashi, 2014).  It is the responsibility of the PMHNP to understand their clients’ profiles and medical histories in order to properly prescribe the most effective medications with the least adverse effects.
REFERENCES
Kusumi, I., Boku, S., & Takahashi, Y. (2014).  Psychopharmacology of atypical antipsychotic drugs: From the recpetor binding profile to neuroprotection and neurogenesis.  Psychiatry and Clinical Neurosciences, 69(5): 243-258. doi: 10.1111/pcn.12242.
Pleuvry, B. (2004).  Receptors, agonists, and antagonists.  Anaesthesia & Intensive Care Medicine, 5(10): 350-352.  doi: 10.1383/anes.5.10.350.52312.
Rasool, M., Malik, A., Naseer, M., Manan, A., Ansari, S., Begum, I.,…Gan, S. (2015).  The role of epigenetics in personalized medicine: Challenges and opportunites.  BMC Medical Genomics, 8(Suppl 1): S5.  doi: 10.1186/1755-8794-8-S1-S5.
Stahl, S. (2013).  Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.).  New York, NY: Cambridge University Press.